Publications by authors named "Tamim Nashad"
Introduction: Clinically significant post-endoscopic retrograde cholangiopancreatography (ERCP) bleeding (CSPEB) is common. Contemporary estimates of risk are lacking. We aimed to identify risk factors of and outcomes after CSPEB.
View Article and Find Full Text PDFArticle Synopsis
- Clinically significant post-endoscopic retrograde cholangiopancreatography (ERCP) bleeding (CSPEB) occurs in about 1.5% of procedures, often following higher-risk interventions like sphincterotomies, with patients frequently needing endoscopy and transfusions.
- Key risk factors for CSPEB include the use of antiplatelet medications (like P2Y12 inhibitors) and anticoagulants (like warfarin and dabigatran), which significantly increase the likelihood of bleeding.
- The study suggests that endoscopists may underestimate the bleeding risks associated with these medications, emphasizing the need for improved management of antithrombotic therapy during the periprocedural period to enhance
Article Synopsis
- Infection transmission after endoscopic retrograde cholangiopancreatography (ERCP) can happen due to contaminated duodenoscopes, even after they undergo high-level disinfection.
- A study aimed to compare contamination rates and technical performance between duodenoscopes with disposable elevator caps and standard designs, involving 518 patients across two Canadian ERCP centers.
- Results showed that disposable elevator caps significantly reduced microbial contamination rates (3.8% vs. 11.2%) and did not compromise the technical success of ERCP procedures.